CRVS
Price
$12.91
Change
-$0.03 (-0.23%)
Updated
Sep 11 closing price
Capitalization
1.08B
47 days until earnings call
Intraday BUY SELL Signals
RZLT
Price
$4.22
Change
+$0.05 (+1.20%)
Updated
Sep 11 closing price
Capitalization
406.35M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRVS vs RZLT

CRVS vs RZLT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRVS vs. RZLT commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVS is a Hold and RZLT is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRVS($1.08B) has a higher market cap than RZLT($406M). RZLT YTD gains are higher at: 78.814 vs. CRVS (67.662). CRVS has higher annual earnings (EBITDA): -56.85M vs. RZLT (-87.22M). CRVS has more cash in the bank: 215M vs. RZLT (120M). CRVS has less debt than RZLT: CRVS (728K) vs RZLT (1.11M). CRVS (0) and RZLT (0) have equivalent revenues.
CRVSRZLTCRVS / RZLT
Capitalization1.08B406M267%
EBITDA-56.85M-87.22M65%
Gain YTD67.66278.81486%
P/E RatioN/AN/A-
Revenue00-
Total Cash215M120M179%
Total Debt728K1.11M66%
FUNDAMENTALS RATINGS
CRVS vs RZLT: Fundamental Ratings
CRVS
RZLT
OUTLOOK RATING
1..100
6393
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
57100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
4451
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RZLT's Valuation (30) in the null industry is somewhat better than the same rating for CRVS (74) in the Pharmaceuticals Major industry. This means that RZLT’s stock grew somewhat faster than CRVS’s over the last 12 months.

CRVS's Profit vs Risk Rating (57) in the Pharmaceuticals Major industry is somewhat better than the same rating for RZLT (100) in the null industry. This means that CRVS’s stock grew somewhat faster than RZLT’s over the last 12 months.

CRVS's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as RZLT (98) in the null industry. This means that CRVS’s stock grew similarly to RZLT’s over the last 12 months.

CRVS's Price Growth Rating (44) in the Pharmaceuticals Major industry is in the same range as RZLT (51) in the null industry. This means that CRVS’s stock grew similarly to RZLT’s over the last 12 months.

CRVS's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as RZLT (100) in the null industry. This means that CRVS’s stock grew similarly to RZLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRVSRZLT
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 2 days ago
90%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (CRVS: $12.91 vs. RZLT: $4.22)
Brand notoriety: CRVS and RZLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRVS: 137% vs. RZLT: 101%
Market capitalization -- CRVS: $1.08B vs. RZLT: $406.35M
CRVS [@Biotechnology] is valued at $1.08B. RZLT’s [@Biotechnology] market capitalization is $406.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRVS’s FA Score shows that 0 FA rating(s) are green while RZLT’s FA Score has 1 green FA rating(s).

  • CRVS’s FA Score: 0 green, 5 red.
  • RZLT’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRVS and RZLT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRVS’s TA Score shows that 4 TA indicator(s) are bullish while RZLT’s TA Score has 5 bullish TA indicator(s).

  • CRVS’s TA Score: 4 bullish, 5 bearish.
  • RZLT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RZLT is a better buy in the short-term than CRVS.

Price Growth

CRVS (@Biotechnology) experienced а -10.28% price change this week, while RZLT (@Biotechnology) price change was -7.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

CRVS is expected to report earnings on Oct 29, 2026.

RZLT is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CRVS
Daily Signal:
Gain/Loss:
RZLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADNAX22.790.16
+0.71%
American Beacon ARK Transfmt Innov A
CWGFX82.110.03
+0.04%
American Funds Cptl Wld Gr&Inc F-1
HNCJX23.10N/A
N/A
Hartford International Growth I
SPISX81.81N/A
N/A
Invesco S&P 500 Index R6
FNKFX18.80N/A
N/A
Fidelity Mid-Cap Stock K6

CRVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVS has been closely correlated with ACRS. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRVS jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVS
1D Price
Change %
CRVS100%
-0.23%
ACRS - CRVS
66%
Closely correlated
-3.36%
RZLT - CRVS
42%
Loosely correlated
+1.20%
AMLX - CRVS
36%
Loosely correlated
-1.46%
IMNM - CRVS
35%
Loosely correlated
-1.20%
OVID - CRVS
35%
Loosely correlated
+2.28%
More

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with GRI. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
+1.20%
GRI - RZLT
52%
Loosely correlated
-2.06%
DYN - RZLT
43%
Loosely correlated
-1.14%
SYRE - RZLT
42%
Loosely correlated
+2.13%
CRVS - RZLT
41%
Loosely correlated
-0.23%
IDYA - RZLT
41%
Loosely correlated
+0.37%
More